A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer
Clinical trial NCT00872014 · COMPLETED
Trial details
- NCT number
- NCT00872014
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2011-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.